SAVA Q4 2020 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-0.09

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$238,000

Balance Sheet

Total Assets

$94M

Total Liabilities

$2M

Stockholders' Equity

$92M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$738,000	-105.8%
Operating Income	-$3M	-$2M	-66.5%
Net Income	-$3M	-$2M	-72.7%